ALB and neoplasm: The bioavailability of albumin-bound paclitaxel (Abraxane) in the tumor is facilitated by the gp60 receptor (albondin)-mediated pathway in the endothelial cell walls of tumors, which binds to albumin with a high affinity [152,153,154].